Mission-aligned partnerships The foundation’s core mission to eliminate financial barriers in the transplant process suggests strong alignment with healthcare access initiatives, patient support programs, and philanthropy-focused partners looking to fund or enable medication adherence, financial assistance, and care coordination services.

Growth via collaboration Recent collaboration with CareDx to improve post-transplant medication adherence indicates openness to strategic partnerships that enhance patient outcomes; explore opportunities with post-transplant care platforms, digital adherence tools, and outcome-based programs.

Technology footprint The organization uses a multi-platform tech stack (Drupal, WordPress, Zendesk, Shopify, Google Workspace, Vercel, WP Engine) which signals a modern digital presence and potential for scalable donor engagement, CRM, e-commerce for fundraising, and customer service integrations.

Financial scale Revenue in the $1M–$10M range with a lean employee base (11–50) suggests a nimble organization that could be receptive to cost-effective, high-impact solutions in fundraising, grant management, and program administration without large enterprise-level commitments.

Leadership continuity New leadership as of 2023 (CEO Jared Wall) and a history of board-level appointments indicate potential readiness for business development outreach, especially with executive-facing initiatives, strategic alliances, and pilot programs centered on expanding access and equity in transplant care.